A rapid positive influence of S-ketamine on the anxiety of patients in palliative care: a retrospective pilot study
Autor: | M. Neukirchen, Matthias Lutterbeck, Ina Grau, Peter Kienbaum, Daniel Schlieper, Joachim Cordes, J Schwartz, Patrick van Caster, Eduard Falk |
---|---|
Rok vydání: | 2020 |
Předmět: |
Adult
Male medicine.medical_specialty Palliative care medicine.drug_class Esketamine lcsh:Special situations and conditions Analgesic Pilot Projects Psychological distress Anxiety Anxiolytic 03 medical and health sciences 0302 clinical medicine Total pain Multivariate analysis of variance Internal medicine medicine Humans Ketamine Depression (differential diagnoses) Aged Retrospective Studies S-ketamine Analysis of Variance Depression business.industry lcsh:RC952-1245 Palliative Care General Medicine Middle Aged 030227 psychiatry Anti-Anxiety Agents Female medicine.symptom business 030217 neurology & neurosurgery Research Article medicine.drug |
Zdroj: | BMC Palliative Care BMC Palliative Care, Vol 19, Iss 1, Pp 1-15 (2020) |
ISSN: | 1472-684X |
DOI: | 10.1186/s12904-019-0499-1 |
Popis: | Background Patients in palliative care need rapid-acting pharmacological options for psychological distress. N-methyl-D-aspartate antagonist ketamine is known to have a fast onset of anti-depressant and anxiolytic action. Its S-enantiomer S-ketamine (or esketamine) is an analgesic used as a routine treatment for refractory pain as an intravenous infusion (0.25 mg/kg over 45 min). This study investigates whether S-ketamine pain therapy has a positive impact on psychological distress caused by anxiety and depression in palliative care. Methods Patient routine data from a palliative care unit of a tertiary care hospital were used in a retrospective analysis after positive ethics approval. Eight patients, who received analgesic S-ketamine treatment, were compared to a control group matched by gender and age. The main analysis was conducted using three-way mixed MANOVA followed by two-way mixed ANOVA. Target variables were the values for anxiety and depression in the state-trait anxiety-depression inventory STADI. The predictor variables were the time of measurement before (T1) and after (T2) S-ketamine application and group membership. Results Comparison of the S-ketamine group (n = 8; 4 male, 4 female; average age 52 years) with the control group (n = 8; 3 male, 5 female; average age 55 years) revealed a significant multivariate effect on anxiety and depression F(1, 14) = 4.78; p = 0.046; r = 0.50. The univariate comparisons showed a significant reduction of the anxiety scores from T1 to T2 in the S-ketamine group compared to the control group F(1, 14) = 10.14; p = 0.007; r = 0.65. With regard to depression, there was no significant reduction from T1 to T2 in the group comparison F(1, 14) = 1.60; p = 0.23; r = 0.32. No long-lasting effects on pain were found. Conclusions Our findings show that psychological distress of patients in palliative care may improve after a single administration of S-ketamine, which mainly alleviates anxiety in those patients. Limitations of this study arise from non-randomization, retrospective analysis and low sample size. Therefore, further prospective and ideally randomized studies are necessary. |
Databáze: | OpenAIRE |
Externí odkaz: |